BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Diagnostic Odyssey in ALS - Patient #2: Bulbar Onset

Activity Snapshot

Activity Type: 
Print/PDF
Release Date: 
Monday, April 4, 2022
Sponsor Information: 

Supported in part by a medical education grant from Mitsubishi Tanabe Pharma America

Faculty

Martina Wiedau, MD
University of California Medical Center, Los Angelas, California
Activity Overview: 

This case study will explore the diagnostic odyssey of Bulbar Onset ALS in patient #2 (59-year-old-man).

Learning Objectives: 
  • Recognize clinical symptoms indicative of amyotrophic lateral sclerosis (ALS)
  • Understand risk factors and genetic causes of ALS Understand the optimal workflow for diagnosis based upon physical examination, a detailed patient history, electrodiagnostic testing, genetic testing, and a variety of additional specialized tests, as needed
  • Understand the use of the ALSFRS-R scale to evaluate functional impairment in patients with ALS
  • Diagnose ALS with increased skill and confidence, shortening the diagnostic journey of patients with ALS
  • Understand how to optimize medical management of confirmed ALS according to best practice guidelines